Position in MAZE
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$287,359
-$365 QoQ
Shares Held
9,630
-0.1% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#2
of 7 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MAZE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Falcon Wealth Planning holds $477,545 across 2 Biotechnology names. MAZE ranks #1 (60.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MAZE |
Maze Therapeutics, Inc.
This page
|
9,630 | $287,359 | |
| 2 | GNLX |
GENELUX Corp
|
63,185 | $190,186 |
All Filings in MAZE
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $287,359 | 9,630 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $287,724 | 9,639 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $415,542 | 10,030 | Shares | Sole | 2026-02-03 | |
| No filing history on record for this holder in this stock. | ||||||